iifl-logo

Sarda Proteins Ltd Board Meeting

124.75
(0.00%)
May 5, 2025|12:00:00 AM

Sarda Proteins CORPORATE ACTIONS

10/05/2024calendar-icon
10/05/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting8 Apr 20258 Apr 2025
Outcome of Board Meeting held today i.e, 8th April, 2025
Board Meeting17 Jan 202513 Jan 2025
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2025 inter alia to consider and approve Unaudited financial results for the quarter and nine months ended on 31st December 2024. The Board of Directors approved the unaudited financial results for the quarter and nine months ended on 31st December 2024. (As Per BSE Announcement dated on 17.01.2025)
Board Meeting24 Dec 202418 Dec 2024
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/12/2024 inter alia to consider and approve proposal for fund raising through issue of fresh Equity Shares and / or Convertible Warrants. Outcome of Board Meeting (As Per Bse Announcement Dated on 24.12.2024)
Board Meeting8 Nov 202426 Oct 2024
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve unaudited financial results for the quarter and half year ended on 30th September 2024. The Board of Directors approved the unaudited financial results for the quarter and half year ended on 30th September 2024 in their Board Meeting held today, 8th November 2024. The Board Meeting started at 6.00 pm and was concluded at 7.00 pm on the same day. (As Per BSE Announcement Dated on: 08/11/2024)
Board Meeting26 Oct 202426 Oct 2024
Appointment of Company Secretary and Compliance officer.
Board Meeting4 Sep 202411 Sep 2024
The Meeting of the Board of Directors of the Company was held on 4th September 2024 and the outcome of the Meeting was also given on the same date. Revised outcome of the Board meeting is being filed for the Board Meeting held on 4th September 2024 pursuant to SEBI Circular No. SEBI/HO/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023 with additional details. Please note that the Board of Directors of the Company in their Meeting held today, September 4, 2024 have considered and approved, amongst the other things, the following: 1. Appointment of Mr. Chirag Thumar as Managing Director of the Company. 2. Alteration of Main Object of the Company to start the business in the power sector. 3. Change of Name of the Company. 4. Shifting of Registered office of the Company from the State of Maharashtra to the State of Gujarat. 5. Approved notice of the 33rd Annual General Meeting of the Company. 33rd Annual General Meeting of the Company will be held on Saturday, 28th September 2024 at 4.00 pm through Audio / Visual means. (As Per BSE Announcement Dated on: 04/09/2024)
Board Meeting12 Aug 202431 Jul 2024
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the Un-audited Financial Results of the company for the quarter ended on 30th June 2024 to take on record the Limited Review Report on the Un-audited Financial Results for the quarter ended on 30th June 2024 and to consider any other business as per the agenda. The Board of Directors of the Company in their meeting held on Monday, 12th August, 2024 at the Corporate Office of the company situated at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302018 (Rajasthan) which commenced at 04:00 P.M. and concluded at 05:45 P.M. , transacted the businesses as attached.
Board Meeting17 Jul 202417 Jul 2024
Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we would like to inform that the Board of Directors of the Company in their meeting held on Wednesday, 17th day of July, 2024 at the Corporate Office of the company at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur- 302018 (Rajasthan) which commenced at 02:00 P.M. and concluded at 03:00 P.M. inter alia transacted businesses as enclosed.
Board Meeting24 Jun 202424 Jun 2024
Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we would like to inform that the Board of Directors of the Company in their meeting held on Monday, 24th day of June, 2024 at the Corporate Office of the company at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur- 302018 (Rajasthan) which commenced at 12:00 P.M. and concluded at 12:30 P.M. inter alia considered and approved the Appointment of Mr. Khilan Hareshbhai Savaliya (DIN: 08790209) as the Additional Director (Non-Executive) of the Company on the recommendation of Nomination and Remuneration Committee in pursuance to Section 161 of the Companies Act, 2013, w.e.f. Monday, 24th day of June, 2024.
Board Meeting28 May 202428 May 2024
Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we would like to inform that the Board of Directors of the Company in their meeting held on Tuesday, 28th day of May, 2024 at the Corporate Office of the company at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur- 302018 (Rajasthan) which commenced at 05:00 P.M. and concluded at 06:00 P.M. inter alia considered and approved the appointment of Mr. Chirag Shantilal Thumar (DIN: 10640822) as the Additional Director (Executive) of the Company on the recommendation of Nomination and Remuneration Committee in pursuance to Section 161 of the Companies Act, 2013, w.e.f. Tuesday, 28th May, 2024. Read less.. Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we would like to inform that the Board of Directors of the Company in their meeting held on Tuesday, 28th day of May, 2024 at the Corporate Office of the company at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur- 302018 (Rajasthan) which commenced at 05:00 P.M. and concluded at 06:00 P.M. inter alia considered and approved the appointment of Mr. Chirag Shantilal Thumar (DIN: 10640822) as the Additional Director (Executive) of the Company on the recommendation of Nomination and Remuneration Committee in pursuance to Section 161 of the Companies Act, 2013, w.e.f. Tuesday, 28th May, 2024. Read less.. (As Per BSE Announcement Dated on 28.05.2024)

Sarda Proteins: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.